IMEXF (Imagin Medical) Short-Term Debt: $8.31 Mil (As of Jun. 2023)


What is Imagin Medical Short-Term Debt?

Imagin Medical IMEXF -99.00% Short-Term Debt is $8.31 Mil as of Jun. 2023.

Imagin Medical's Short-Term Debt for the quarter that ended in Jun. 2023 was $8.31 Mil.

Imagin Medical's quarterly Short-Term Debt increased from Dec. 2022 ($9.50 Mil) to Mar. 2023 ($9.90 Mil) but then declined from Mar. 2023 ($9.90 Mil) to Jun. 2023 ($8.31 Mil).

Imagin Medical's annual Short-Term Debt increased from Sep. 2020 ($0.00 Mil) to Sep. 2021 ($9.25 Mil) and increased from Sep. 2021 ($9.25 Mil) to Sep. 2022 ($10.09 Mil).

Imagin Medical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Imagin Medical Short-Term Debt Related Terms

Imagin Medical Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Short-Term Debt Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 9.25 10.09

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 10.09 9.50 9.90 8.31
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $8.31 Mil mean?
Imagin Medical (IMEXF) has a Short-Term Debt of $8.31 Mil as of Jun. 2023.
Is Imagin Medical's Short-Term Debt too high?
Imagin Medical's current Short-Term Debt is $8.31 Mil.
How does Imagin Medical's Short-Term Debt compare to ABT and SYK?
Imagin Medical's Short-Term Debt of $8.31 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Imagin Medical's current Short-Term Debt is $8.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Short-Term Debt of $8.31 Mil. The current Short-Term Debt is $8.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Short-Term Debt is $8.31 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.